Works matching AU Oki, Masahide


Results: 50
    1
    2
    3

    Phase II study of carboplatin plus weekly paclitaxel with bevacizumab for non-squamous, non-small cell lung cancer with idiopathic interstitial pneumonia (Hanshin Cancer Group IP002).

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 1, p. 67, doi. 10.1093/jjco/hyae132
    By:
    • Katakami, Nobuyuki;
    • Nagata, Kazuma;
    • Nakakura, Akiyoshi;
    • Okamoto, Tadashi;
    • Kaneda, Toshihiko;
    • Oki, Masahide;
    • Watanabe, Kana;
    • Tokito, Takaaki;
    • Amano, Yoshihiro;
    • Tamiya, Motohiro;
    • Morita, Satoshi;
    • Hatachi, Yukimasa
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.

    Published in:
    BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03212-5
    By:
    • Taniguchi, Yoshihiko;
    • Tamiya, Akihiro;
    • Osuga, Mitsuo;
    • Harada, Daijiro;
    • Isa, Shun-ichi;
    • Nakamura, Keiichi;
    • Mizumori, Yasuyuki;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Tamura, Atsuhisa;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17

    Authors' Reply.

    Published in:
    Respiration, 2013, v. 86, n. 5, p. 440, doi. 10.1159/000355322
    By:
    • Oki, Masahide;
    • Saka, Hideo
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Pleomorphic Adenoma of the Trachea.

    Published in:
    Respiration, 2010, v. 80, n. 5, p. 433, doi. 10.1159/000308462
    By:
    • Kajikawa, Shigehisa;
    • Oki, Masahide;
    • Saka, Hideo;
    • Moritani, Suzuko
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non–Small Cell Lung Cancer.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 12, p. e2347700, doi. 10.1001/jamanetworkopen.2023.47700
    By:
    • Sakamoto, Tomohiro;
    • Matsubara, Taichi;
    • Takahama, Takayuki;
    • Yokoyama, Toshihide;
    • Nakamura, Atsushi;
    • Tokito, Takaaki;
    • Okamoto, Tatsuro;
    • Akamatsu, Hiroaki;
    • Oki, Masahide;
    • Sato, Yuki;
    • Tobino, Kazunori;
    • Ikeda, Satoshi;
    • Mori, Masahide;
    • Mimura, Chihiro;
    • Maeno, Ken;
    • Miura, Satoru;
    • Harada, Toshiyuki;
    • Nishimura, Kunihiro;
    • Hiraoka, Manabu;
    • Kenmotsu, Hirotsugu
    Publication type:
    Article
    31
    32

    Thin bronchoscopic cryobiopsy using a nasobronchial tube.

    Published in:
    BMC Pulmonary Medicine, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12890-022-02166-w
    By:
    • Oki, Masahide;
    • Saka, Hideo;
    • Kogure, Yoshihito;
    • Niwa, Hideyuki;
    • Ishida, Akane;
    • Yamada, Arisa;
    • Torii, Atsushi;
    • Kitagawa, Chiyoe
    Publication type:
    Article
    33
    34

    Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 79, doi. 10.1007/s10147-022-02266-x
    By:
    • Katakami, Nobuyuki;
    • Yokoyama, Toshihide;
    • Morita, Satoshi;
    • Okamoto, Tatsuro;
    • Urata, Yoshiko;
    • Hattori, Yoshihiro;
    • Iwamoto, Yasuo;
    • Sato, Yuki;
    • Ikeda, Norihiko;
    • Takahashi, Toshiaki;
    • Daga, Haruko;
    • Oguri, Tetsuya;
    • Fujisaka, Yasuhito;
    • Nishino, Kazumi;
    • Sugawara, Shunichi;
    • Kozuki, Toshiyuki;
    • Oki, Masahide;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    35
    36

    Circulating Tumour DNA in Patients With EGFR‐Mutated Non‐Small‐Cell Lung Cancer and Early Disease Progression After First‐Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70861
    By:
    • Tamiya, Akihiro;
    • Mizumori, Yasuyuki;
    • Osuga, Mitsuo;
    • Isa, Shun‐ichi;
    • Taniguchi, Yoshihiko;
    • Nakamura, Keiichi;
    • Harada, Daijiro;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Tamura, Atsuhisa;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    37

    Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single‐plex testing: WJOG13620L.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 23, p. 21097, doi. 10.1002/cam4.6668
    By:
    • Uemura, Takehiro;
    • Kenmotsu, Hirotsugu;
    • Hazama, Daisuke;
    • Teraoka, Shunsuke;
    • Kobe, Hiroshi;
    • Azuma, Koichi;
    • Yamaguchi, Teppei;
    • Masuda, Takeshi;
    • Yokoyama, Toshihide;
    • Otsubo, Kohei;
    • Haratani, Koji;
    • Hayakawa, Daisuke;
    • Oki, Masahide;
    • Takemoto, Shinnosuke;
    • Ozaki, Tomohiro;
    • Akashi, Yusaku;
    • Hata, Akito;
    • Hashimoto, Hiroya;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    38
    39
    40
    41
    42

    Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 11, p. 1783, doi. 10.1038/s41416-024-02662-2
    By:
    • Haratani, Koji;
    • Nakamura, Atsushi;
    • Mamesaya, Nobuaki;
    • Sawa, Kenji;
    • Shiraishi, Yoshimasa;
    • Saito, Ryota;
    • Tanizaki, Junko;
    • Tamura, Yosuke;
    • Hata, Akito;
    • Tsuruno, Kosuke;
    • Sakamoto, Tomohiro;
    • Teraoka, Shunsuke;
    • Oki, Masahide;
    • Watanabe, Hiroshi;
    • Tokito, Takaaki;
    • Nagata, Kenji;
    • Masuda, Takeshi;
    • Nakamura, Yasushi;
    • Sakai, Kazuko;
    • Chiba, Yasutaka
    Publication type:
    Article
    43

    Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.

    Published in:
    Investigational New Drugs, 2025, v. 43, n. 1, p. 101, doi. 10.1007/s10637-024-01500-9
    By:
    • Taniguchi, Yoshihiko;
    • Tamiya, Akihiro;
    • Osuga, Mitsuo;
    • Isa, Shun-ichi;
    • Nakamura, Keiichi;
    • Mizumori, Yasuyuki;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Shimada, Masahiro;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    44

    World Association for Bronchology and Interventional Pulmonology (WABIP) guidelines on airway stenting for malignant central airway obstruction.

    Published in:
    Respirology, 2024, v. 29, n. 7, p. 563, doi. 10.1111/resp.14764
    By:
    • Chaddha, Udit;
    • Agrawal, Abhinav;
    • Kurman, Jonathan;
    • Ortiz‐Comino, Rosamaria;
    • Dutau, Herve;
    • Freitag, Lutz;
    • Trisolini, Rocco;
    • Dooms, Christophe;
    • Zuccatosta, Lina;
    • Gasparini, Stefano;
    • Herth, Felix;
    • Saka, Hideo;
    • Lee, Pyng;
    • Fielding, David;
    • Oki, Masahide;
    • Rosell, Antoni;
    • Murgu, Septimiu
    Publication type:
    Article
    45
    46
    47

    EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial.

    Published in:
    Respirology, 2022, v. 27, n. 2, p. 152, doi. 10.1111/resp.14182
    By:
    • Crombag, Laurence M. M.;
    • Mooij‐Kalverda, Kirsten;
    • Szlubowski, Artur;
    • Gnass, Maciej;
    • Tournoy, Kurt G.;
    • Sun, Jiayuan;
    • Oki, Masahide;
    • Ninaber, Maarten K.;
    • Steinfort, Daniel P.;
    • Jennings, Barton R.;
    • Liberman, Moishe;
    • Bilaceroglu, Semra;
    • Bonta, Peter I.;
    • Korevaar, Daniël A.;
    • Trisolini, Rocco;
    • Annema, Jouke T.
    Publication type:
    Article
    48
    49
    50